How Analysts Rated Heska Corporation (NASDAQ:HSKA) Last Week?

February 25, 2018 - By Michael Collier

 How Analysts Rated Heska Corporation (NASDAQ:HSKA) Last Week?
Investors sentiment increased to 1.26 in 2017 Q3. Its up 0.01, from 1.25 in 2017Q2. It is positive, as 16 investors sold Heska Corporation shares while 37 reduced holdings. 24 funds opened positions while 43 raised stakes. 5.53 million shares or 0.49% more from 5.51 million shares in 2017Q2 were reported.
Kj Harrison Prtnrs Incorporated reported 15,000 shares. Public Sector Pension Invest Board holds 0% in Heska Corporation (NASDAQ:HSKA) or 3,954 shares. State Of Wisconsin Inv Board holds 5,000 shares or 0% of its portfolio. Strs Ohio accumulated 0% or 7,600 shares. Moreover, Tower Rech Capital (Trc) has 0.01% invested in Heska Corporation (NASDAQ:HSKA) for 1,689 shares. Nicholas Investment Partners Lp holds 0.15% or 25,296 shares in its portfolio. Cortina Asset Management Limited Liability Corporation has invested 0.25% in Heska Corporation (NASDAQ:HSKA). Vanguard Grp, a Pennsylvania-based fund reported 501,907 shares. Moreover, Teton Inc has 0.09% invested in Heska Corporation (NASDAQ:HSKA). Ftb Advisors invested in 0% or 31 shares. Mufg Americas Corporation holds 16 shares. Moreover, Bancshares Of Montreal Can has 0% invested in Heska Corporation (NASDAQ:HSKA) for 17,867 shares. Tokio Marine Asset Management Com Limited owns 0.06% invested in Heska Corporation (NASDAQ:HSKA) for 4,400 shares. New York State Common Retirement Fund holds 9,597 shares or 0% of its portfolio. Albion Grp Ut has invested 0.08% in Heska Corporation (NASDAQ:HSKA).

Since August 30, 2017, it had 0 insider purchases, and 2 sales for $348,184 activity. 825 shares valued at $84,327 were sold by Wisnewski Nancy on Thursday, August 31.

Heska Corporation (NASDAQ:HSKA) Ratings Coverage

Among 8 analysts covering Heska Corp (NASDAQ:HSKA), 4 have Buy rating, 0 Sell and 4 Hold. Therefore 50% are positive. Heska Corp had 13 analyst reports since August 25, 2015 according to SRatingsIntel. As per Tuesday, August 1, the company rating was maintained by Gabelli. CL King downgraded the stock to “Neutral” rating in Thursday, January 26 report. Benchmark maintained the stock with “Buy” rating in Wednesday, March 1 report. CL King initiated the shares of HSKA in report on Friday, April 1 with “Neutral” rating. Gabelli downgraded Heska Corporation (NASDAQ:HSKA) on Thursday, August 4 to “Hold” rating. On Tuesday, November 29 the stock rating was initiated by Benchmark with “Buy”. The firm earned “Hold” rating on Tuesday, August 25 by TheStreet. Below is a list of Heska Corporation (NASDAQ:HSKA) latest ratings and price target changes.

04/12/2017 Broker: Raymond James Rating: Buy
03/11/2017 Broker: FBR Capital Rating: Hold New Target: $93.0
27/10/2017 Broker: B. Riley & Co Rating: Hold New Target: $96.5
05/10/2017 Broker: Canaccord Genuity Rating: Buy New Target: $115 Initiates Coverage On

The stock increased 1.05% or $0.63 during the last trading session, reaching $60.59. About 47,148 shares traded. Heska Corporation (NASDAQ:HSKA) has risen 162.64% since February 25, 2017 and is uptrending. It has outperformed by 145.94% the S&P500.

Heska Corporation develops, manufactures, and markets advanced veterinary diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Europe, and internationally. The company has market cap of $438.90 million. It operates through two divisions, Core Companion Animal Health; and Other Vaccines, Pharmaceuticals and Products. It has a 31.77 P/E ratio. The Core Companion Animal Health segment offers Element DC and DRI-CHEM 7000 veterinary chemistry analyzers for blood chemistry and electrolyte analysis; HT5 and HEMATRUE veterinary hematology analyzers to measure white and red blood cell count, platelet count, and hemoglobin levels in animals; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and IV pumps.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: